Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H22ClN3 |
Molecular Weight | 291.819 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCCNC1=CC=NC2=CC(Cl)=CC=C12
InChI
InChIKey=NCPLTAGJJVCHOW-UHFFFAOYSA-N
InChI=1S/C16H22ClN3/c1-3-20(4-2)11-5-9-18-15-8-10-19-16-12-13(17)6-7-14(15)16/h6-8,10,12H,3-5,9,11H2,1-2H3,(H,18,19)
Molecular Formula | C16H22ClN3 |
Molecular Weight | 291.819 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
AQ-13 is a drug candidate in development for the treatment of Plasmodium falciparum infections. The chemical structure is similar to chloroquine, a 4-aminoquinoline, with a shorter diaminoalkane side chain. The outstanding attribute of AQ-13 is its retrieval of activity against chloroquine-resistant P.falciparum. The most likely future indication of AQ-13 could be case management of uncomplicated falciparum malaria - as a partner drug in a combination therapy.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17213921
10, 100, 300, 600, and 1,500 mg oral doses
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19331176
AQ-13 inhibited NO production by LPS-stimulated mouse macrophage-like cells with IC50 value of 8 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:15:49 GMT 2023
by
admin
on
Sat Dec 16 05:15:49 GMT 2023
|
Record UNII |
4K7VT5621X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
494715
Created by
admin on Sat Dec 16 05:15:49 GMT 2023 , Edited by admin on Sat Dec 16 05:15:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID10186268
Created by
admin on Sat Dec 16 05:15:49 GMT 2023 , Edited by admin on Sat Dec 16 05:15:49 GMT 2023
|
PRIMARY | |||
|
32571-49-6
Created by
admin on Sat Dec 16 05:15:49 GMT 2023 , Edited by admin on Sat Dec 16 05:15:49 GMT 2023
|
PRIMARY | |||
|
4K7VT5621X
Created by
admin on Sat Dec 16 05:15:49 GMT 2023 , Edited by admin on Sat Dec 16 05:15:49 GMT 2023
|
PRIMARY | |||
|
3805581
Created by
admin on Sat Dec 16 05:15:49 GMT 2023 , Edited by admin on Sat Dec 16 05:15:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |